Business Wire

2022 IBSA Foundation Fellowship Record Number of Applications for the 10th Year of the Programme Supporting Researchers Under 40

Share

With 211 projects submitted, a record number of applications were received for the 2022 Fellowships sponsored by IBSA Foundation for scientific research, marking an important milestone for the tenth anniversary of the programme that rewards young researchers from universities and research institutes around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230414005335/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

©IBSA - IBSA Foundation Fellowships 2022 Awards Ceremony - Arturo Licenziati, Silvia Misiti, Luisa Lambertini and 4 winners

The award ceremony for the 6 winning projects was held today in Lugano, at the IBSA cosmos plant; the six were chosen out of more than two hundred submitted by young researchers and were each granted a scholarship worth €30,000. The number of applicants was very high, confirming the trend of greater participation by female than male researchers in recent years (61% vs 39%). In addition, participants in the 2022 call came from a total of 29 countries.

Projects were received in five scientific fields – dermatology, endocrinology, fertility / urology, pain medicine / orthopedics / rheumatology, and the special category for 2022 dedicated to Healthy Aging.

Here are the winners:

  • Laura Yerly, Department of Dermatology and Venereology, Hôpital de Beaumont, Lausanne University Hospital Center, 1011 (Switzerland)
    Project Title: Dissecting the cellular and molecular interactions governing perineural invasion in cutaneous squamous cell carcinoma patients to identify novel therapeutic strategies .
  • Camilla Basso, Laboratory for Surgical Translational Research, Department of Surgery, Ente Ospedaliero Cantonale and Faculty of Biomedical Science, Università della Svizzera italiana (Switzerland)
    Project Title: Fat-infiltrating microbiota: a new player in obesity?
  • Valentina Lorenzi, European Molecular Biology Laboratory - European Bioinformatics Institute, Wellcome Sanger Institute, University of Cambridge (UK)
    Project Title: Unraveling the temporal and spatial dynamics of the developing human reproductive ducts.
  • Francesco De Logu, University of Florence, Department of Health Sciences, Laboratory of Clinical Pharmacology and Experimental Oncology (Italy)
    Project Title: tArgeted iNhibition of SChwann cell HORmone pAthway in GendEr pain (ANCHORAGE)
  • Marco Fantuz, VIMM Advanced Biomedical Research Foundation; Department of Biology, University of Padua (Italy)
    Project Title: Can impairments of mitochondria-to-nucleus communication explain age-associated decline of humoral immunity?
  • Julio Aguado, Australian Institute for Bioengineering and Nanotechnology AIBN, The University of Queensland (Australia)
    Project Title: Pharmacological targeting of SARS-CoV-2 neuroinvasion and its long-term effect in healthy brain aging.

At the award ceremony, the scholarships were presented by Arturo Licenziati, President and CEO of IBSA Group, Silvia Misiti, Director of IBSA Foundation for scientific research, and Luisa Lambertini, Appointed Rector of the Università della Svizzera italiana.

Supporting cutting-edge research and projects to advance society and open up new avenues of scientific research: this is the goal we aim to achieve by renewing the call for the Fellowship programme every year” – explains Silvia Misiti, Director of IBSA Foundation “We have been pursuing this commitment for 10 years now and we will continue to do so, because we believe in the talent of today's young researchers, in helping them become the scientists of tomorrow”.

IBSA Foundation is in fact continuing its commitment to research and young talent and is launching a new call for applications for the 2023 Fellowship programme. The next round of Fellowships will be awarded to 6 innovative and distinctive projects in the scientific fields of dermatology, endocrinology, fertility / urology, pain medicine / orthopaedics / rheumatology, and the 2023 special category of “Healthy Aging/Regenerative Medicine”. Projects dealing with at least one of these areas of research will therefore be accepted in the field of Healthy Aging / Regenerative Medicine.

Another aspect that is different this year is the economic value of each scholarship, which has been increased to €32,000.

Candidates who intend to apply with their project can submit proposals on the dedicated platform no later than 31 December, 2023.

IBSA Foundation for scientific research
IBSA Foundation for scientific research was established in 2012 in Lugano. It is the main promoter of IBSA Group's corporate social responsibility activities. IBSA Foundation supports scientific research and promotes dissemination through education, art and science, culture, and health-related activities. Its vision is going beyond treatment, with full awareness of the importance of the benefits of combining treatment paths with participation in cultural activities. Its mission is to promote an authoritative and accessible scientific culture through science dissemination, international science network, and support for research. Among its various initiatives, IBSA Foundation offers high-level forums with internationally renowned speakers and scholarships for basic and clinical research in various fields.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS INFORMATION

I BSA Press Office for Switzerland Laboratorio delle Parole
Francesca Rossini – notizie@laboratoriodelleparole.net – mob: +41 77 417 93 72

IBSA Press Office for Italy – Noesis PR
Valeria Riccobono – valeria.riccobono@noesis.net – mob: +39 392 9625892
Ornella Reccia – ornella.reccia@noesis.net – mob. +39 329 3931922

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MOGAS Mourns the Death of Their Beloved Chairman and Founder Vincent Louis Mogas3.5.2024 20:30:00 EEST | Press release

MOGAS mourns the death of their beloved chairman and founder Vincent Louis Mogas, who died on May 2, 2024 in Houston, Texas. Louis spent his life building a valve manufacturing business and a company culture that stood for goodness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240503919754/en/ V. Louis Mogas, Founder and Chairman of MOGAS Industries (1939 - 2024) (Photo: MOGAS Industries Inc.) MOGAS Industries was formed in May 1973 when Louis Mogas purchased a small machine shop in Houston. He soon acquired the rights to service and manufacture ball valves from Cameron Iron Works. Under Louis' leadership, the Company studied valve failures and established an R&D department that customized valves for specific applications. Since 2000, MOGAS has established sales and service offices in Australia, China, Europe, Canada, South America, Middle East and India. Early on, Louis Mogas introduced business behaviors that became the

Ververica Achieves ISO 27001 Certification, Bolstering Data Security3.5.2024 19:08:00 EEST | Press release

Ververica, a comprehensive streaming data platform provider, announces the achievement of ISO 27001 certification, a significant milestone in its commitment to data security and governance. This certification is internationally recognized as the gold standard for information security management systems (ISMS), and demonstrates the company’s commitment to protecting sensitive corporate and customer data against emerging cyber threats. For Ververica and its customers, this ensures that data is managed under the strictest security protocols, enhancing trust and confidence in Ververica’s ability to handle sensitive information securely and effectively. Ververica's security operations utilize Vanta, a trusted third-party management platform, for rigorous real-time monitoring and security alerts. To further enhance transparency and customer trust, Ververica has introduced a dedicated Trust Center webpage where stakeholders and potential customers can review live detailed information about se

Lone Star Announces Acquisition of ERIKS3.5.2024 16:07:00 EEST | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate has acquired ERIKS N.V., a specialized pan-European industrial components distributor and engineering service provider. Financial terms of the transaction were not disclosed. Founded in 1940, ERIKS has established itself as a European leader in specialized industrial services with over 200 locations in 12 countries. ERIKS’ deep industry experience, technical knowledge, local distribution network and dedicated engineering facilities allow it to develop advanced, customized solutions that drive performance improvements, deliver cost savings and add measurable technical and commercial value for its customers. Donald Quintin, Chief Executive Officer and Global President of Lone Star, said, "ERIKS represents an exciting investment opportunity and a valuable addition to our European investment portfolio. This acquisition aligns with our strategy of investing in market leading businesses that exhibit both growth and operating imp

Mars, Incorporated Enters Exclusive Discussions to Acquire the Entire Stake in French Veterinary Diagnostics Businesses Cerba Vet and ANTAGENE Held by the Cerba HealthCare Group3.5.2024 16:00:00 EEST | Press release

Mars, Incorporated today announced that it has entered into exclusive discussions with Cerba HealthCare with a view to acquiring Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Headquartered in Massy, France, Cerba Vet is a network of six veterinary diagnostics laboratories in France and Switzerland. With approximately 140 Associates, Cerba Vet provides full animal-related service diagnostics with complete clinical and anatomic pathology testing as well as endocrinology, microbiology, serology, hematology, chemistry, and other advanced tests, to veterinary practitioners. Cerba Vet is recognized by veterinarians in France for its medical expertise and pioneering continuous education program, the Cerba Vet College, with weekly live webinars and several practical sessions annually. Headquartered in Lyon, France, ANTAGENE is a leading player in animal genetics in Europe, recognised for its expertise in DNA testing for dogs, cats, horses and wildlife. ANTAGENE offers tests glo

Adtran and GLDS integrate Mosaic CP with BroadHub® for enhanced broadband service billing and management3.5.2024 15:00:00 EEST | Press release

Adtran today announced that GLDS’s customer management and billing platform, BroadHub®, is now integrated with Adtran’s Mosaic CP and its SDX Series of optical line terminals (OLTs). Building on a longstanding partnership, the collaboration enhances automated service management by enabling instantaneous adjustments to network conditions and rapid responses to customer demands. It promises to boost service capabilities and operational efficiencies for service providers globally, offering advanced scalability for growing networks and real-time data analytics for improved service management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240503338277/en/ Adtran’s partnership with GLDS is helping service providers simplify customer management and streamline billing processes. (Photo: Business Wire) “Our strategic partnership with Adtran is driven by a shared commitment to empowering service providers with robust customer managem

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye